L'Oréal leads funding round for Chinese biotech PAM2L Biotechnologies, an AI-native biomaterials R&D company. The investment was made through L'Oréal's corporate venture capital fund BOLD.
Round Type
Venture
ShenzhenBiotechnologyArtificial IntelligenceInvestors
Description
L'Oréal has made a minority investment in PAM2L Biotechnologies, an artificial intelligence-native biomaterials R&D and application company in China. The investment was made through Shanghai Meicifang Investment Co with support from L'Oréal's strategic corporate venture capital fund BOLD. L'Oréal will leverage its beauty and formulation expertise to explore innovative bio-actives, including Augmented Colanic Acid. PAM2L was also a L'Oréal Big Bang Beauty Tech Innovation Program winner in 2024.
Quick answer
PAM2L Biotechnologies raised an undisclosed amount in a funding round, dated November 12, 2026. Investors: Guangxin Group, Guangzhou Pharmaceutical Group, Walgreens Boots Alliance and L’oréal. PAM2L Biotechnologies is based in Shenzhen, Guangdong, China.
- How much did PAM2L Biotechnologies raise?
- PAM2L Biotechnologies raised an undisclosed amount in a funding round on November 12, 2026.
- Who invested in PAM2L Biotechnologies?
- Guangxin Group, Guangzhou Pharmaceutical Group, Walgreens Boots Alliance and L’oréal are named as investors in this round.
- What does PAM2L Biotechnologies do?
- PAM2L Biotechnologies is an AI-native biomaterials R&D and application company founded in 2021 by Dr Zhong Chao from the Shenzhen Institutes of Advanced Technology.
- Where is PAM2L Biotechnologies based and how big is it?
- PAM2L Biotechnologies is based in Shenzhen, Guangdong, China.
Source: Fundz verified event record.
Who else raised in Biotechnology and Artificial Intelligence around the same time
Companies in the same sectors as PAM2L Biotechnologies that raised within 45 days of this round, from Fundz verified event records.
- Kardi Ai raised $5.9M (Series A) on November 11, 2026.
- Switchpoint Bio raised $5.3M (Pre-Seed) on November 11, 2026.
- Alterra Labs raised $13M (Seed) on November 10, 2026.
- Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
- Vale Biolabs raised $183K (Pre-Seed) on November 9, 2026.
- Potential Sciences raised an undisclosed amount (Seed) on November 5, 2026.
Who to call at PAM2L Biotechnologies, and when
A new round usually means PAM2L Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PAM2L Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PAM2L Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PAM2L Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PAM2L Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
PAM2L Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.